Loading...

Home
ETF
AUTL

AUTL

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

AUTL News

Asgard Therapeutics Appoints New Chief Medical Officer

6d agoseekingalpha

Autolus Therapeutics to Participate in Investor Conferences

Apr 07 2026Newsfilter

Autolus Therapeutics Reports Strong 2025 Earnings with AUCATZYL Launch Success

Mar 27 2026seekingalpha

AUCATZYL® 2025 Financial Results and Market Outlook

Mar 27 2026Newsfilter

Autolus Therapeutics Q4 Earnings Report Analysis

Mar 27 2026seekingalpha

Autolus Therapeutics Earnings Announcement Scheduled

Mar 26 2026seekingalpha

Precision Biologics Market Awakens to $71 Billion Opportunity

Feb 05 2026Globenewswire

Precision Biologics Market Awakens to $71 Billion Opportunity

Feb 05 2026Newsfilter

Gelteq Ltd Reports 22% Bioavailability Increase in Cannabinoid Oral Gel, Shares Surge 50.1%

Jan 14 2026Benzinga

Autolus Evaluates Cellares' Automated Platform for Manufacturing Expansion

Jan 06 2026Newsfilter

Ultragenyx Shares Plunge 42% Following Phase 3 Study Failures for Setrusumab

Dec 29 2025Benzinga

DigitalBridge Group Inc Acquired by SoftBank Group for Approximately $4 Billion

Dec 29 2025Benzinga

BTIG Raises Praxis Precision Medicines Price Target to $843

Dec 29 2025Benzinga

GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4 with 10μg/kg Dose

Dec 19 2025PRnewswire

GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4 with 10μg/kg/day Dosing

Dec 19 2025Newsfilter

Autolus Unveils New Phase I Results for Obe-cel in Challenging Lupus Cases

Dec 09 2025NASDAQ.COM